Today

Agents

Chat

Arena

Discover

More

App

Acadia Pharmaceuticals: Deutsche Bank cuts target price to $27 from $30

ACAD•2026-11-11

Deutsche Bank cut its target price for Acadia Pharmaceuticals to $27 from $30.

Related News

C

Camping World Holdings Inc: Truist Securities cuts target price to $7 from $10

CWH•2026-11-11

Clearway Energy: Deutsche Bank raises target price to $42 from $40

CWEN•2026-11-11

Capri Holdings names Estee Lauder senior executive Justin Boxford new CEO

CPRI•2026-11-11

Needham cuts Velo3D target price to $12 from $33

VELO•2026-11-11

Nurix Therapeutics appoints Arati V. Rao as chief medical officer

NRIX•2026-11-11

Acadia Pharmaceuticals: Deutsche Bank cuts target price to $27 from $30 - ACAD News | Rallies